Peroxisome proliferator activated receptor alpha activation decreases inflammatory and destructive responses in osteoarthritic cartilage
Open accessAbstract
Objective Peroxisome proliferator activated receptor α (PPARα) agonists are used in clinical practice as lipid-lowering drugs and are also known to exert anti-inflammatory effects on various tissues. We hypothesized that PPARα activation leads to anti-inflammatory and anti-destructive effects in human OA cartilage.Methods Cartilage explants obtained from six OA patients were cultured for 48 h with 10 ng/ml interleukin (IL)1β as a pro-inflammatory stimulus. 100 μM Wy-14643, a potent and selective PPARα agonist, was added to the cultures and gene expression of matrix metalloproteinase (MMP)1, MMP3, MMP13, collagen type II (COL2A1), aggrecan and PPARα in cartilage explants and the release of glycosaminoglycans (GAGs), nitric oxide (NO) and prostaglandin E(2) (PGE(2)) in the culture media were analyzed and compared to the control without Wy-14643.Results Addition of Wy-14643 decreased mRNA expression of MMP1, MMP3 and MMP13 in cartilage explants that responded to IL1β, whereas Wy-14643 did not affect gene expression of COL2A1 and aggrecan. Wy-14643 also decreased secretion of inflammatory marker NO in the culture medium of cartilage explants responding to IL1β. Wy-14643 inhibited the release of GAGs by cartilage explants in culture media.Conclusion PPARα agonist Wy-14643 inhibited the inflammatory and destructive responses in human OA cartilage explants and did not have an effect on COL2A1 or aggrecan mRNA expression. These effects of PPARα agonists on osteoarthritic cartilage warrant further investigation of these drugs as a potential therapeutic strategy for osteoarthritis (OA).
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
PPARα is an established modulator of lipid metabolism.
“the PPARα nuclear receptor was of prime interest because is an established modulator of lipid metabolism”
From Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy (2019) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519 · see citing works
Farndale, R. W., Buttle, D. J., & Barrett, A. J. (1986) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(86)90306-5 · Cited by 3,313 · see citing works
Biochemical and Metabolic Abnormalities in Articular Cartilage from Osteo-Arthritic Human Hips
Mankin, H. J., DORFMAN, H., Lippiello, L., & Zarins, A. (1971) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-197153030-00009 · Cited by 1,969 · see citing works
Charalambous, C. P. (2013) · Springer eBooks · doi:10.1007/978-1-4471-5451-8_97 · Cited by 1,845 · see citing works
The PPARα–leukotriene B4 pathway to inflammation control
Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W. (1996) · Nature · doi:10.1038/384039a0 · Cited by 1,345 · see citing works
Krey, G. D., Braissant, O., L’Horset, F., Kalkhoven, E., Perroud, M., Parker, M. G., & Wahli, W. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.6.0007 · Cited by 1,221 · see citing works
Goldring, M. B., & Goldring, S. R. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21258 · Cited by 1,179 · see citing works
Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M., & Kliewer, S. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3406 · Cited by 1,110 · see citing works
Delerive, P., De Bosscher, K., Besnard, S., Vanden Berghe, W., Peters, J. M., Gonzalez, F. J., Fruchart, J.-C., Tedgui, A., Haegeman, G., & Staels, B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32048 · Cited by 1,089 · see citing works
Biochemical and Metabolic Abnormalities in Articular Cartilage from Osteo-Arthritic Human Hips
Mankin, H. J., & Lippiello, L. (1970) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-197052030-00002 · Cited by 854 · see citing works
Lemberger, T., Desvergne, B., & Wahli, W. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.335 · Cited by 704 · see citing works
The Role of Cytokines in Cartilage Matrix Degeneration in Osteoarthritis
Goldring, S. R., & Goldring, M. B. (2004) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000144854.66565.8f · Cited by 655 · see citing works
NF-κB Signaling: Multiple Angles to Target OA
Marcu, K. B., Otero, M., Olivotto, E., Borzı̀, R. M., & Goldring, M. B. (2010) · Current Drug Targets · doi:10.2174/138945010791011938 · Cited by 567 · see citing works
Cartilage in normal and osteoarthritis conditions
Martel‐Pelletier, J., Boileau, C., Pelletier, J., & Roughley, P. J. (2008) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2008.02.001 · Cited by 556 · see citing works
Delerive, P., Martin‐Nizard, F., Chinetti, G., Trottein, F., Fruchart, J., Najïb, J., Duriez, P., & Staels, B. (1999) · Circulation Research · doi:10.1161/01.res.85.5.394 · Cited by 502 · see citing works
Association between weight or body mass index and hand osteoarthritis: a systematic review
Yusuf, E., Nelissen, R. G. H. H., Ioan‐Facsinay, A., Stojanovic-Susulic, V., DeGroot, J., van Osch, G. J. V. M., Middeldorp, S., Huizinga, T. W. J., & Kloppenburg, M. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.106930 · Cited by 445 · see citing works
Clockaerts, S., Bastiaansen-Jenniskens, Y. M., Runhaar, J., van Osch, G. J. V. M., Offel, J. F. V., Verhaar, J. A. N., Clerck, L. S. D., & Somville, J. (2010) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2010.03.014 · Cited by 433 · see citing works
Self-citationGlucosamine inhibits IL-1β-induced NFκB activation in human osteoarthritic chondrocytes
Largo, R., Alvarez-Soria, M. A., Dı́ez-Ortego, I., Calvo, E., Sánchez‐Pernaute, O., Egido, J., & Herrero‐Beaumont, G. (2003) · Osteoarthritis and Cartilage · doi:10.1016/s1063-4584(03)00028-1 · Cited by 386 · see citing works
The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis
McCoy, J. M., Wicks, J. R., & Audoly, L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15528 · Cited by 360 · see citing works
TNF-induced structural joint damage is mediated by IL-1
Zwerina, J., Redlich, K., Polzer, K., Joosten, L., Krönke, G., Distler, J., Hess, A., Pundt, N., Pap, T., Hoffmann, O., et al. (2007) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0610812104 · Cited by 322 · see citing works
The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis
McCoy, J. M., Wicks, J. R., & Audoly, L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215528 · Cited by 320 · see citing works
Vascular pathology and osteoarthritis
Findlay, D. M. (2007) · Rheumatology · doi:10.1093/rheumatology/kem191 · Cited by 304 · see citing works
Reduced Pain Hypersensitivity and Inflammation in Mice Lacking Microsomal Prostaglandin E Synthase-1
Kamei, D., Yamakawa, K., Takegoshi, Y., Mikami-Nakanishi, M., Nakatani, Y., Oh‐ishi, S., Yasui, H., Azuma, Y., Hirasawa, N., Ohuchi, K., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400199200 · Cited by 278 · see citing works
Metalloproteases and inhibitors in arthritic diseases
Martel‐Pelletier, J., Welsch, D. J., & Pelletier, J. (2001) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2001.0195 · Cited by 270 · see citing works
Ligand Selectivity of the Peroxisome Proliferator-Activated Receptor α
Lin, Q., Ruuska, S. E., Shaw, N. S., Dong, D., & Noy, N. (1999) · Biochemistry · doi:10.1021/bi9816094 · Cited by 263 · see citing works
Nitric oxide in inflammation and pain associated with osteoarthritis
Abramson, S. B. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2463 · Cited by 232 · see citing works
PPARα in atherosclerosis and inflammation
Zandbergen, F. J., & Plutzky, J. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.04.021 · Cited by 215 · see citing works
Peroxisome Proliferator-Activated Receptor α Agonists as Therapy for Autoimmune Disease
Lovett‐Racke, A. E., Hussain, R. Z., Northrop, S. C., Choy, J., Rocchini, A., Matthes, L., Chavis, J. A., Diab, A., Drew, P. D., & Racke, M. K. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5790 · Cited by 207 · see citing works
Is progressive osteoarthritis an atheromatous vascular disease?
Conaghan, P. G., Vanharanta, H., & Dieppe, P. A. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.039263 · Cited by 207 · see citing works
Peroxisome Proliferator-Activated Receptor α Protects against Obesity-Induced Hepatic Inflammation
Stienstra, R., Mandard, S., Patsouris, D., Maass, C., Kersten, S., & Müller, M. M. (2007) · Endocrinology · doi:10.1210/en.2007-0014 · Cited by 191 · see citing works
Zainal, Z., Longman, A. J., Hurst, S., Duggan, K., Caterson, B., Hughes, C., & Harwood, J. L. (2009) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2008.12.009 · Cited by 141 · see citing works
Bordji, K., Grillasca, J., Gouze, J.-N., Magdalou, J., Schohn, H., Keller, J., Bianchi, A., Dauça, M., Netter, P., & Terlain, B. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.12243 · Cited by 134 · see citing works
Forsyth, C. B., Cole, A. A., Murphy, G., Bienias, J. L., Im, H.-J., & Loeser, R. F. (2005) · The Journals of Gerontology Series A · doi:10.1093/gerona/60.9.1118 · Cited by 125 · see citing works
Okamoto, H., Iwamoto, T., Kotake, S., Momohara, S., Yamanaka, H., & Kamatani, N. (2005) · PubMed · Cited by 113 · see citing works
Cheng, S., Afif, H., Martel‐Pelletier, J., Pelletier, J., Li, X., Farrajota, K., Lavigne, M. J. F., & Fahmi, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402828200 · Cited by 112 · see citing works
Davies-Tuck, M. L., Hanna, F. S., Davis, S. R., Bell, R. J., Davison, S. L., Wluka, A. E., Adams, J., & Cicuttini, F. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2873 · Cited by 112 · see citing works
Vascular mechanisms in osteoarthritis
Ghosh, P. B., & Cheras, P. A. (2001) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2001.0188 · Cited by 98 · see citing works
Fukui, N., Ikeda, Y., Ohnuki, T., Tanaka, N., Hikita, A., Mitomi, H., Mori, T., Juji, T., Katsuragawa, Y., Yamamoto, S., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23175 · Cited by 87 · see citing works
Afif, H., Benderdour, M., Endam, L. M., Martel‐Pelletier, J., Pelletier, J., Duval, N., & Fahmi, H. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2151 · Cited by 84 · see citing works
Remick, J. S., WEINTRAUB, H. S., Setton, R. A., Offenbacher, J., Fisher, E. A. A., & Schwartzbard, A. Z. (2008) · Cardiology in Review · doi:10.1097/crd.0b013e31816b43d3 · Cited by 83 · see citing works
Crisafulli, C., & Cuzzocrea, S. (2009) · Shock · doi:10.1097/shk.0b013e31818bbad6 · Cited by 74 · see citing works
PPARα attenuates the proinflammatory response in activated mesangial cells
Kono, K., Kamijo, Y., Hora, K., Takahashi, K., Higuchi, M., Kiyosawa, K., Shigematsu, H., Gonzalez, F. J., & Aoyama, T. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00484.2007 · Cited by 53 · see citing works
Goldring, M., & Berenbaum, F. (1999) · Osteoarthritis and Cartilage · doi:10.1053/joca.1998.0219 · Cited by 45 · see citing works
François, M., Richette, P., Tsagris, L., Fitting, C., May, C. L., Benallaoua, M., Tahiri, K., & Corvol, M. T. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21728 · Cited by 42 · see citing works
Patel, N. S. A., Paola, R. D., Mazzon, E., Britti, D., Thiemermann, C., & Cuzzocrea, S. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146191 · Cited by 40 · see citing works
Ikawa, H., Kameda, H., Kamitani, H., Baek, S. J., Nixon, J. B., Hsi, L. C., & Eling, T. E. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5233 · Cited by 39 · see citing works
Poleni, P.-E., Bianchi, A., Etienne, S., Koufany, M., Sébillaud, S., Netter, P., Terlain, B. L., & Jouzeau, J. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.10.009 · Cited by 38 · see citing works
Peroxisome proliferator-activated receptors
Ziouzenkova, O., Perrey, S., Marx, N., Bacqueville, D., & Plutzky, J. (2002) · Current Atherosclerosis Reports · doi:10.1007/s11883-002-0063-x · Cited by 37 · see citing works
The Role of Analgesics and Intra-articular Injections in Disease Management
Harvey, W. F., & Hunter, D. J. (2008) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2008.05.006 · Cited by 34 · see citing works
Poleni, P.-E., Etienne, S., Velot, É., Netter, P., & Bianchi, A. (2010) · PPAR Research · doi:10.1155/2010/635912 · Cited by 24 · see citing works
Offel, J. F. V., Dombrecht, E. J., Bridts, C. H., Schuerwegh, A. J., Ebo, D. G., Stevens, W. J., & Clerck, L. S. D. (2005) · Cytokine · doi:10.1016/j.cyto.2005.05.009 · Cited by 22 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, Wahli W. The PPARalpha-leukotriene B4 p.thway to inflam- mation control. Nature 1996;384:39e43.
Cited by
Sorted by citations
Sacitharan, P. (2019) · Sub-cellular biochemistry · doi:10.1007/978-981-13-3681-2_6 · Cited by 113 · see citing works
Fahy, N., Melle, M. L. D. V., Lehmann, J., Wei, W., Grotenhuis, N., Farrell, E., van der Kraan, P. M., Murphy, M. J., Bastiaansen-Jenniskens, Y. M., & van Osch, G. J. V. M. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.05.021 · Cited by 270 · see citing works
Self-citationFibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy
Nogueira-Recalde, U., Lorenzo-Gómez, I., Blanco, F. J., Loza, M. I., Grassi, D., Shirinsky, V., Shirinsky, I., Lotz, M., Robbins, P. D., Domínguez, E., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.06.049 · Cited by 155 · see citing works
The emerging role of fibroblast‐like synoviocytes‐mediated synovitis in osteoarthritis: An update
Han, D., Fang, Y., Tan, X., Jiang, H., Gong, X., Wang, X., Hong, W., Tu, J., & Wei, W. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15669 · Cited by 138 · see citing works
Ballegaard, C., Riis, R., Bliddal, H., Christensen, R., Henriksen, M., Bartels, E. M., Lohmander, S. L., Hunter, D. J., Bouert, R., & Boesen, M. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.04.018 · Cited by 124 · see citing works
Clockaerts, S., Bastiaansen-Jenniskens, Y. M., Feijt, C., Clerck, L. S. D., Verhaar, J. A. N., Zuurmond, A., Stojanovic-Susulic, V., Somville, J., Kloppenburg, M., & van Osch, G. J. V. M. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200688 · Cited by 101 · see citing works
Self-citationNuclear Receptors in Bone Physiology and Diseases
Imai, Y., Youn, M., Inoue, K., Takada, I., Kouzmenko, A., & Kato, S. (2013) · Physiological Reviews · doi:10.1152/physrev.00008.2012 · Cited by 89 · see citing works
Park, S., Baek, I., Ryu, J. H., Chun, C. H., & Jin, E. (2022) · Nature Communications · doi:10.1038/s41467-021-27738-y · Cited by 80 · see citing works
Melle, M. L. D. V., Narcisi, R., Kops, N., Koevoet, W. J. L. M., Bos, P. K., Murphy, M. J., Verhaar, J. A. N., van der Kraan, P. M., & van Osch, G. J. V. M. (2013) · Tissue Engineering Part A · doi:10.1089/ten.tea.2013.0080 · Cited by 64 · see citing works
Self-citationDunn, S. L., Wilkinson, J. M., Crawford, A., Bunning, R. A. D., & Le Maitre, C. L. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2015.0001 · Cited by 62 · see citing works
Room Ee16.14, D. M. 5., Melle, M. D. V.-V., Tihaya, M. S., Kops, N., Koevoet, W., Murphy, J., Verhaar, J., Alini, M., Eglin, D., & van Osch, G. (2014) · European Cells and Materials · doi:10.22203/ecm.v027a09 · Cited by 51 · see citing works
Self-citationDunn, S. L., Wilkinson, J. M., Crawford, A., Le Maitre, C. L., & Bunning, R. A. D. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2013.10.016 · Cited by 46 · see citing works
Osteoarthritis: Role of Peroxisome Proliferator-Activated Receptors
Sheng, W., Wang, Q., Qin, H., Cao, S., Wei, Y., Weng, J., Yu, F., & Zeng, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713137 · Cited by 44 · see citing works
Physiologic and pathologic effects of dietary free fatty acids on cells of the joint
Harasymowicz, N. S., Dicks, A. R., Wu, C., & Guilak, F. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13999 · Cited by 43 · see citing works
Adipokine Signaling Pathways in Osteoarthritis
Zhang, C., Lin, Y., Yan, C. H., & Zhang, W. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.865370 · Cited by 38 · see citing works
Cellular ageing mechanisms in osteoarthritis
Sacitharan, P. K., & Vincent, T. L. (2016) · Mammalian Genome · doi:10.1007/s00335-016-9641-z · Cited by 37 · see citing works
Bastiaansen-Jenniskens, Y. M., Siawash, M., van de Lest, C. H. A., Verhaar, J. A. N., Kloppenburg, M., Zuurmond, A. ‐., Stojanovic-Susulic, V., van Osch, G. J. V. M., & Clockaerts, S. (2013) · Cartilage · doi:10.1177/1947603513494401 · Cited by 37 · see citing works
Self-citationZhou, P., Xiang, L., Yang, Y.-L., Wu, Y., Hu, T., Liu, X.-L., Lin, F.-T., Xiu, Y., Wu, K., Lu, C.-Z., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104264 · Cited by 32 · see citing works
Zhou, Y., Chen, X., Qu, N., Zhang, B., & Xia, C. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14184 · Cited by 31 · see citing works
Narcisi, R., Signorile, L., Verhaar, J. A. N., Giannoni, P., & van Osch, G. J. V. M. (2012) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2012.06.010 · Cited by 27 · see citing works
Self-citationSchwarz, S., Mrosewski, I., Silawal, S., & Schulze-Tanzil, G. G. (2017) · Inflammation Research · doi:10.1007/s00011-017-1121-8 · Cited by 26 · see citing works
Statins and fibrates do not affect development of spontaneous cartilage damage in STR/Ort mice
Wei, W., Clockaerts, S., Bastiaansen-Jenniskens, Y. M., Gierman, L. M., Botter, S. M., Bierma‐Zeinstra, S., Weinans, H., Verhaar, J. A. N., Kloppenburg, M., Zuurmond, A. ‐., et al. (2013) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2013.11.009 · Cited by 25 · see citing works
Self-citationFibrates as therapy for osteoarthritis and rheumatoid arthritis? A systematic review
van Eekeren, I. C. M., Clockaerts, S., Bastiaansen-Jenniskens, Y. M., Lubberts, E., Verhaar, J. A. N., van Osch, G. J. V. M., & Bierma‐Zeinstra, S. (2013) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x12468659 · Cited by 22 · see citing works
Self-citationPDK4 inhibits osteoarthritis progression by activating the PPAR pathway
Li, Z., Xie, L., Zeng, H., & Wu, Y. (2024) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-024-04583-5 · Cited by 20 · see citing works
Alsalem, M., Haddad, M., Aldossary, S. A., Kalbouneh, H., Altarifi, A., Jaffal, S. M., Abbas, M. A., Aldaoud, N., & El‐Salem, K. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00584-7 · Cited by 20 · see citing works
Cannabinoids: Novel Therapies For Arthritis?
Dunn, S. L., Wilkinson, J. M., Crawford, A., Maitre, C. L. L., & Bunning, R. A. D. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.20 · Cited by 18 · see citing works
Role of peroxisome proliferator-activated receptors in osteoarthritis (Review)
Huang, G., Jiang, W. H., Xie, W., Lü, W., Zhu, W., & Deng, Z. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11798 · Cited by 18 · see citing works
Jung, J. I., Lee, H. S., Jeon, Y. E., Kim, S. M., Hong, S. H., Moon, J. M., Lim, C. Y., Kim, Y. H., & Kim, E. J. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00870-3 · Cited by 19 · see citing works
Wang, Z., Wang, M., Xu, X., Liu, Y., Chen, Q., Wu, B., & Zhang, Y. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149128 · Cited by 17 · see citing works
Yu, X., Zhao, L., Yu, Z., Yu, C., Bi, J., Binglong, S., & Cong, H. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4684 · Cited by 17 · see citing works
Duesterdieck‐Zellmer, K. F., Driscoll, N., & Ott, J. F. (2012) · American Journal of Veterinary Research · doi:10.2460/ajvr.73.10.1530 · Cited by 14 · see citing works
Genuine traditional Korean medicine, BaekJeol-Tang for the treatment of rheumatoid arthritis
Han, N., Sim, W.-M., Sul, M.-C., Kim, M., Lee, C., Kim, D., Lee, S.-H., Lee, H.-C., Ryu, J.-M., Nam, B.-S., et al. (2013) · TANG [HUMANITAS MEDICINE] · doi:10.5667/tang.2013.0010 · Cited by 13 · see citing works
PPARD is an Inhibitor of Cartilage Growth in External Ears
Zhang, Z., Duan, Y., Wu, Z., Zhang, H., Ren, J., & Huang, L. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.19714 · Cited by 11 · see citing works
Li, H., Li, X., Yang, B., Su, J., Cai, S., Huang, J., Hu, T., Chen, L., Xu, Y., & Li, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-96517-y · Cited by 11 · see citing works
Costa, M. C., Angelini, C., Franzese, M., Iside, C., Salvatore, M., Laezza, L., Napolitano, F., & Ceccarelli, M. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05006-z · Cited by 10 · see citing works
Adopted orphans as regulators of inflammation, immunity and skeletal homeostasis
Ipseiz, N., Scholtysek, C., Culemann, S., & Krönke, G. (2014) · Swiss Medical Weekly · doi:10.4414/smw.2014.14055 · Cited by 8 · see citing works
Wang, C., Tsai, P., Siow, T. Y., Lee, H., Chang, Y., Hsu, Y., Chiang, S., Lin, M., Chung, H., & Huang, G. (2015) · Journal of Orthopaedic Research® · doi:10.1002/jor.22914 · Cited by 8 · see citing works
Castillero, E., Martı́n, A. I., Nieto‐Bona, M. P., Fernández‐Galaz, C., López-Menduiña, M., Villanúa, M. Á., & López‐Calderón, A. (2012) · Endocrine Connections · doi:10.1530/ec-12-0003 · Cited by 8 · see citing works
Zhou, Y., Li, L., Chen, X., Zhao, Q., Qu, N., Zhang, B., Jin, X., & Xia, C. (2023) · European journal of medical research · doi:10.1186/s40001-023-01267-4 · Cited by 7 · see citing works
Pleiotropic effects of PPAR-α – from benchside to bedside
Shirinsky, I. V., & Shirinsky, V. S. (2021) · Medical Immunology (Russia) · doi:10.15789/1563-0625-peo-2222 · Cited by 6 · see citing works
Enamel Matrix Derivative has No Effect on the Chondrogenic Differentiation of Mesenchymal Stem Cells
Groeneveldt, L. C., Knuth, C., Witte‐Bouma, J., O’Brien, F. J., Wolvius, E. B., & Farrell, E. (2014) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2014.00029 · Cited by 6 · see citing works
Ashour, H., Rashed, L. A., Elsebaie, M. M., Sabry, M. M., Abdelmohsen, M. A., & Eissa, M. (2018) · Modern Rheumatology · doi:10.1080/14397595.2018.1508800 · Cited by 3 · see citing works
Yu, C., Qin, J., Zhao, X., Luo, S., Zeng, H., Xu, B., & Li, J. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1751127 · Cited by 2 · see citing works
Hmood, S., Mohammed, M., Hummadi, Y. M. K. A. M., & Jasim, N. A. (2018) · Iraqi journal of Medical Sciences · doi:10.22578/ijms.16.1.14 · Cited by 2 · see citing works
Osteoarthritis in time for senotherapeutics
Véret, D., Jørgensen, C., & Brondello, J. (2020) · Joint Bone Spine · doi:10.1016/j.jbspin.2020.105084 · Cited by 2 · see citing works
Sheng, W., Guo, T., Yu, B., Zhao, J., Hu, C., Lin, J., Weng, J., Chen, Y., Wang, D., Yu, F., et al. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151281 · Cited by 1 · see citing works
Thomas, G. W., Williams, J. S., Bar-Or, R., Hausburg, M. A., Banton, K. L., & Bar‐Or, D. (2026) · Biomedicines · doi:10.3390/biomedicines14092028 · Cited by 1 · see citing works
Aranguren-Abadía, L. (2015) · NORA - Norwegian Open Research Archives · Cited by 1 · see citing works
[Cumulative survival rate of chemotherapy with CDDP for malignant ovarian tumors].
Takada, M., Usui, N., Yoshida, K., Hirayama, H., Suzuki, M., TAKEUCHI, H., Wada, H., Iwasa, T., Yamamoto, T., & Nagasawa, I. (1990) · PubMed · Cited by 1 · see citing works
PPARα activation in portal hypertension
Liu, H., Lee, S. S., Groszmann, R. J., Iwakiri, Y., & Taddei, T. H. (2012) · Hepatology · doi:10.1002/hep.26045
Mohammed, M. M. (2018) · International Journal of Research in Pharmaceutical Sciences · doi:10.26452/ijrps.v9ispl1.1408
L’arthrose à l’heure des sénothérapies
Véret, D., Jørgensen, C., & Brondello, J. (2021) · Revue du Rhumatisme · doi:10.1016/j.rhum.2021.09.009
Tot jugant a la cara fosca: el treball de les ombres a l'escola bressol
Bonastre, M. J., & Vega, S. (1999) · Dialnet (Universidad de la Rioja)
Jung, J. I., Lee, H. S., Jeon, Y. E., Kim, S. M., Hong, S. H., Moon, J. M., Lim, C. Y., Kim, Y. H., & Kim, E. J. (2021) · Research Square · doi:10.21203/rs.3.rs-629822/v1 · Cited by 1 · see citing works
Senolytic Development in Osteoarthritis: A New Paradigm
(2021) · Integrative Journal of Orthopaedics and Traumatology · doi:10.31038/ijot.2021422
Costa, M. C., Angelini, C., Franzese, M., Iside, C., Salvatore, M., Laezza, L., Napolitano, F., & Ceccarelli, M. (2024) · Figshare · doi:10.6084/m9.figshare.26693919
Costa, M. C., Angelini, C., Franzese, M., Iside, C., Salvatore, M., Laezza, L., Napolitano, F., & Ceccarelli, M. (2024) · Figshare · doi:10.6084/m9.figshare.26693928
Zhou, Y., Li, L., Chen, X., Zhao, Q., Qu, N., Zhang, B., Jin, X., & Xia, C. (2024) · Figshare · doi:10.6084/m9.figshare.26616175
Costa, M. C., Angelini, C., Franzese, M., Iside, C., Salvatore, M., Laezza, L., Napolitano, F., & Ceccarelli, M. (2024) · Figshare · doi:10.6084/m9.figshare.26693913
Costa, M. C., Angelini, C., Franzese, M., Iside, C., Salvatore, M., Laezza, L., Napolitano, F., & Ceccarelli, M. (2024) · Figshare · doi:10.6084/m9.figshare.26693922
Additional file 1 of PDK4 inhibits osteoarthritis progression by activating the PPAR pathway
Li, Z., Xie, L., Zeng, H., & Wu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26675933
Zhou, Y., Li, L., Chen, X., Zhao, Q., Qu, N., Zhang, B., Jin, X., & Xia, C. (2024) · Figshare · doi:10.6084/m9.figshare.26616172
Costa, M. C., Angelini, C., Franzese, M., Iside, C., Salvatore, M., Laezza, L., Napolitano, F., & Ceccarelli, M. (2024) · Figshare · doi:10.6084/m9.figshare.26693925
Costa, M. C., Angelini, C., Franzese, M., Iside, C., Salvatore, M., Laezza, L., Napolitano, F., & Ceccarelli, M. (2024) · Figshare · doi:10.6084/m9.figshare.26693916
Additional file 2 of PDK4 inhibits osteoarthritis progression by activating the PPAR pathway
Li, Z., Xie, L., Zeng, H., & Wu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26675936
Hang, W., Triantafilou, K., & Zhou, Y. (2026) · Current Rheumatology Reports · doi:10.1007/s11926-026-01229-9
- Authors
- Clockaerts, S., Bastiaansen-Jenniskens, Y. M., Feijt, C., Verhaar, J. A. N., Somville, J., De Clerck, L. S., & Van Osch, G. J. V. M.
- Affiliations
- University of Antwerp (BE)
- Erasmus MC (NL)
- Venue
- Osteoarthritis and Cartilage
- Publisher
- Elsevier BV
- Published
- 2011-07
- Volume
- 19
- Issue
- 7
- Pages
- 895-902
- ISSN
- 1063-4584 (ISSN-L)
- OpenAlex
- W1986584261
- Cited by
- 65
- References
- 51
- Citations by year
- 2026: 4 · 2024: 9 · 2023: 3 · 2022: 2 · 2021: 6 · 2020: 3 · 2019: 6 · 2018: 5 · 2017: 3 · 2016: 2 · 2015: 2 · 2014: 5 · 2013: 7 · 2012: 6
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Osteoarthritis and Cartilage (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Funders
- Top Institute Pharma
- Universiteit Antwerpen
- Topics
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Keywords
- PPARα agonist, osteoarthritis, articular cartilage, Wy-14,643, IL-1β, matrix metalloproteinases, MMP-1, MMP-3, MMP-13, type II collagen, aggrecan, nitric oxide, prostaglandin E2, glycosaminoglycans, cartilage degeneration, anti-inflammatory therapy
- MeSH terms
- Cartilage, Articular, Cells, Cultured, Glycosaminoglycans, Humans, Inflammation, Nitric Oxide, Pyrimidines, Dinoprostone, Osteoarthritis, Knee, Matrix Metalloproteinases, Collagen Type II, PPAR alpha, Aggrecans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review